| |
🤖 The Bay Area raked in more than half of all VC dollars spent on AI and machine learning deals in 2024, according to PitchBook data, but some investors at the HumanX conference in Vegas last week warned that more money isn't always better. Find out why
⚖️ HR tech provider Rippling is suing Deel, one of its chief rivals, alleging the latter planted a spy at the company who stole information about customers, pricing and personnel. Read more
🔒 Alphabet is back in talks to acquire buzzy and fast-growing cybersecurity specialist Wiz, according to The Wall Street Journal. This time, the price tag is reportedly $30 billion—a significant bump from its prior talks at $23 billion.
Plus...
• Private credit lenders are looking closely at tariffs
• Healthtech VC dealmaking is showing signs of improvement
• PepsiCo nabs prebiotic beverage company Poppi | | | | | | | | | | |
| |
| Tariffs rise to top of due diligence checklist in private credit | |  | | (Michal Krakowiak/Getty Images) | | | Some private credit lenders are shying away from deals in tariff-sensitive sectors amid rapidly changing policies and heightened market volatility, while others are forging on under pressure to deploy dry powder.
Direct lending dealmaking was suppressed at the start of 2025, as M&A and LBO deal activity were bruised by "a rapidly shifting regulatory environment" and political turmoil, according to PitchBook LCD's US Private Credit Monitor. | | | | | | | |
| |
| A message from PitchBook Data | | |
| Ready to engage top PE and VC audiences? | | Our 2025 PitchBook Media Kit offers service providers direct access to 2.1 million engaged professionals through our targeted newsletters and exclusive reports. Backed by PitchBook's trusted global data, our sponsorships amplify your brand via custom reports, asset class insights, website and native content partnerships.
See what's new for 2025 | | | | | | | |
| |
| Healthtech dealmaking inches toward recovery | | The healthtech market may finally be recovering from a difficult post-pandemic adjustment period, with 179 deals closed in Q4 2024, according to our latest Emerging Tech Research. Overall, 24 mega-rounds worth $100 million-plus were raised last year in the sector, up from 18 in 2023.
Finland-based smart-ring developer Oura led the way with its $200 million Series D at a $5.2 billion valuation. Exit value at the end of 2024 was up slightly from the previous two years. But startups may have to take valuation haircuts or explore other M&A options moving forward in an exit environment that's still far from its peak in 2021. | | | | | | | | | PepsiCo acquires prebiotic soda brand Poppi for nearly $2B | |  | | (Peter Dazeley/Getty Images) | | | | Pepsi has acquired prebiotic soda-maker Poppi in a $1.95 billion deal, expanding its presence in the functional beverage market. The move positions Pepsi to compete with Coca-Cola's SimplyPop as health-conscious consumers increasingly seek better-for-you drink options. | | | | | | | | | India's private markets in flux: IPO boom, VC slowdown, PE resilience | | India's private markets are navigating a mixed landscape—VC dealmaking continued to battle headwinds in 2024, down over 50% from peak levels. Meanwhile, PE has remained more resilient, with non-domestic investors increasing their stakes in the country's high-growth sectors.
Our Q4 2024 India Market Snapshot dives into the macro trends, key deals and what's next as India heads into a shifting economic cycle. | | | | | | | |
| |
| |
| | Since yesterday, the PitchBook Platform added: | | 643 Deals | 2358 People | 615 Companies | 43 Funds | | | | | | |
| |
The Daily Benchmark:
2018 Vintage Global Real Estate Funds | | | | | | |
| |
| |
| |
| |
| |
| |
Latigo Biotherapeutics, which develops non-opioid pain treatments, raised a $150 million Series B led by Blue Owl Capital.
Seattle-based Curevo Vaccine, the developer of a shingles vaccine, raised a $110 million Series B led by Medicxi.
Maxion Therapeutics, a UK-based biotech startup, secured a $72 million Series A led by General Catalyst.
Dalma, a Paris-based pet insurer, raised a €20 million Series B led by Breega.
Gradial, a startup developing AI agents for enterprise marketing, raised a $13 million Series A led by Madrona. | | | | | |
| |
| PitchBook webinar: Focus on private credit CLOs | | Late 2024 saw the debut of Europe's first CLO backed primarily by private credit debt—setting the stage for a wave of similar deals in 2025. But what's next for the market?
In this webinar, we'll examine the significance of this event and provide a general market update on key private credit developments, as well as an overall leveraged finance update for 2025 so far. Key topics include: - How will CLO issuance shape the private credit market in 2025?
- What is next for private credit debt in Europe?
- How does M&A activity compare to projections?
Register now to secure your spot. | | | | | | | |
| |
| |
Investcorp agreed to acquire a majority stake in Miebach Consulting, a Germany-based supply chain management consultancy.
A group of investors led by RRJ Capital has invested $600 million in Dubai-based VistaJet, a private airline group.
Triton Partners acquired a minority stake in Frankfurt-listed waste management and recycling specialist Befesa.
Thoma Bravo invested in cloud-based administration software provider PCMI. | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
No comments:
Post a Comment